Verve Therapeutics Inc (VERV)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
CEO:
Sekar Kathiresan
Employees:
110
500 TECHNOLOGY SQUARE, CAMBRIDGE, MA 02139
(978) 501-3026

Verve Therapeutics, Inc. engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver.

Data derived from most recent annual or quarterly report
Market Cap 1.842 Billion Shares Outstanding48.665 Million Avg 30-day Volume 1.446 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-6.66
Price to Revenue0.0 Debt to Equity0.0031 EBITDA-120.769 Million
Price to Book Value3.0908 Operating Margin0.0 Enterprise Value623.265 Million
Current Ratio11.554 EPS Growth0 Quick Ratio11.358
1 Yr BETA 2.2514 52-week High/Low 78.0 / 10.7 Profit Margin0.0
Operating Cash Flow Growth-120.2909 Altman Z-Score18.2949 Free Cash Flow to Firm 0
Earnings Report2022-11-10
View SEC Filings from VERV instead.

View recent insider trading info

Funds Holding VERV (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VERV

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

385 Thousand total shares from 10 transactions

Exercise Derivative Conversion (M)

130 Thousand total shares from 4 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KATHIRESAN SEKAR CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
807,258 2022-08-10 8

COATS LONNEL

  • Director
0 2022-08-08 2

FMR LLC

  • SEE REMARK 1
570,729 2022-07-26 9

BELLINGER ANDREW CSO & CMO

  • Officer
8,228 2022-07-20 5

ADELMAN BURT A

  • Director
15,500 2022-06-09 4

MACLEAN MICHAEL F

  • Director
15,500 2022-06-09 1

YESHWANT KRISHNA

  • Director
  • 10% Owner
15,500 2022-06-09 1

CUMBO ALEXANDER

  • Director
0 2022-06-09 2

EVANS JOHN M.

  • Director
15,500 2022-06-09 1

MIKHAIL SHEILA

  • Director
15,500 2022-06-09 1

ASHE ANDREW D. SEE REMARKS

  • Officer
125,000 2022-02-11 2

DORVAL ALLISON CHIEF FINANCIAL OFFICER

  • Officer
60,000 2022-02-11 3

ARCH VENTURE PARTNERS X, LLC

ARCH VENTURE FUND X, L.P.

ARCH VENTURE FUND X OVERAGE, L.P.

ARCH VENTURE PARTNERS X, L.P.

ARCH VENTURE PARTNERS X OVERAGE, L.P.

CRANDELL KEITH

NELSEN ROBERT

BUROW KRISTINA

GILLIS STEVEN

  • 10% Owner
No longer subject to file 2021-06-21 0

NOVO HOLDINGS A/S

  • 10% Owner
No longer subject to file 2021-06-21 0

REDMILE GROUP, LLC

GREEN JEREMY

  • 10% Owner
No longer subject to file 2021-06-21 0

CASDIN PARTNERS MASTER FUND, L.P.

  • 10% Owner
No longer subject to file 2021-06-21 0

CORMORANT ASSET MANAGEMENT, LP

CHEN BIHUA

CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

CORMORANT PRIVATE HEALTHCARE FUND III LP

  • Director
  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2021-06-21 0

ROCK SPRINGS CAPITAL MANAGEMENT LP

ROCK SPRINGS CAPITAL MASTER FUND LP

ROCK SPRINGS CAPITAL LLC

  • 10% Owner
No longer subject to file 2021-06-21 0

GV 2017 GP, L.L.C.

GV 2017 GP, L.P.

GV 2017, L.P.

  • 10% Owner
6,320,905 2021-06-21 0

BEAM THERAPEUTICS INC.

  • 10% Owner
No longer subject to file 2021-06-21 0

WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) I L.P.

  • 10% Owner
No longer subject to file 2021-06-21 0

LOGOS GLOBAL MANAGEMENT LP

  • 10% Owner
No longer subject to file 2021-06-21 0

CASDIN PRIVATE GROWTH EQUITY FUND, L.P.

  • 10% Owner
No longer subject to file 2021-06-21 0

GV 2019 GP, L.L.C.

GV 2019 GP, L.P.

GV 2019, L.P.

  • 10% Owner
4,472,509 2021-06-21 0

BROAD INSTITUTE, INC.

  • 10% Owner
No longer subject to file 2021-06-21 0

BEAUDOIN MARGARET VICE PRESIDENT, FINANCE

  • Officer
11,799 2021-06-17 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

KATHIRESAN SEKAR - Director - Officer CHIEF EXECUTIVE OFFICER

2022-08-11 17:00:28 -0400 2022-08-10 M 50,000 d 167,425 direct

KATHIRESAN SEKAR - Director - Officer CHIEF EXECUTIVE OFFICER

2022-08-11 17:00:28 -0400 2022-08-10 S 50,000 $29.90 d 317,839 direct yes 6.3782 6.3782 2 0.0 1

KATHIRESAN SEKAR - Director - Officer CHIEF EXECUTIVE OFFICER

2022-08-11 17:00:28 -0400 2022-08-10 M 50,000 $1.39 a 367,839 direct 6.3782 6.3782 2 0.0 1

COATS LONNEL - Director

2022-08-09 17:05:20 -0400 2022-08-08 A 31,000 a 31,000 direct

BELLINGER ANDREW - Officer CSO & CMO

2022-07-22 17:00:35 -0400 2022-07-20 M 20,000 d 1,599 direct

BELLINGER ANDREW - Officer CSO & CMO

2022-07-22 17:00:35 -0400 2022-07-20 S 20,000 $34.90 d 6,629 direct yes -4.2646 -24.1101 0.0 1 -24.1101 6

BELLINGER ANDREW - Officer CSO & CMO

2022-07-22 17:00:35 -0400 2022-07-20 M 20,000 $1.39 a 26,629 direct -4.2646 -24.1101 0.0 1 -24.1101 6

KATHIRESAN SEKAR - Director - Officer CHIEF EXECUTIVE OFFICER

2022-07-21 17:00:32 -0400 2022-07-19 M 50,000 d 217,425 direct

KATHIRESAN SEKAR - Director - Officer CHIEF EXECUTIVE OFFICER

2022-07-21 17:00:32 -0400 2022-07-19 S 50,000 $29.90 d 317,839 direct yes -2.7115 -19.5688 0.0 1 -19.5688 6

KATHIRESAN SEKAR - Director - Officer CHIEF EXECUTIVE OFFICER

2022-07-21 17:00:32 -0400 2022-07-19 M 50,000 $1.39 a 367,839 direct -2.7115 -19.5688 0.0 1 -19.5688 6

BELLINGER ANDREW - Officer CSO & CMO

2022-07-15 17:00:23 -0400 2022-07-13 M 10,000 $1.48 a 16,629 direct 22.729 13.1889 36.488 3 0.0 1

BELLINGER ANDREW - Officer CSO & CMO

2022-07-15 17:00:23 -0400 2022-07-13 M 10,000 d 136,995 direct

BELLINGER ANDREW - Officer CSO & CMO

2022-07-15 17:00:23 -0400 2022-07-13 S 10,000 $24.90 d 6,629 direct yes 22.729 13.1889 36.488 3 0.0 1

KATHIRESAN SEKAR - Director - Officer CHIEF EXECUTIVE OFFICER sekar kathiresan 2022 annuity trust

2022-07-15 17:00:27 -0400 2022-07-12 G 160,000 a 300,000 indirect

KATHIRESAN SEKAR - Director - Officer CHIEF EXECUTIVE OFFICER sekar kathiresan 2022 annuity trust

2022-07-15 17:00:27 -0400 2022-07-12 G 140,000 a 140,000 indirect

KATHIRESAN SEKAR - Director - Officer CHIEF EXECUTIVE OFFICER

2022-07-15 17:00:27 -0400 2022-07-12 G 160,000 d 445,308 direct

KATHIRESAN SEKAR - Director - Officer CHIEF EXECUTIVE OFFICER

2022-07-15 17:00:27 -0400 2022-07-12 G 140,000 d 291,988 direct

FMR LLC - > 10% Owner SEE REMARK 1 f-prime capital partners healthcare fund v lp

2022-07-14 17:24:23 -0400 2022-07-12 S 63,000 $22.04 d 570,729 indirect 10.9658 29.1016 51.4551 4 0.0 1

FMR LLC - > 10% Owner SEE REMARK 1 f-prime capital partners healthcare fund v lp

2022-07-14 17:24:23 -0400 2022-07-12 S 100,000 $19.98 d 633,729 indirect 10.9658 29.1016 51.4551 4 0.0 1

KATHIRESAN SEKAR - Director - Officer CHIEF EXECUTIVE OFFICER kathiresan family 2021 irrevocable trust

2022-07-15 17:00:27 -0400 2022-07-07 G 160,000 a 240,997 indirect 22.729 13.1889 36.488 3 0.0 1

KATHIRESAN SEKAR - Director - Officer CHIEF EXECUTIVE OFFICER

2022-07-15 17:00:27 -0400 2022-07-07 G 160,000 d 317,839 direct 22.729 13.1889 36.488 3 0.0 1

FMR LLC - > 10% Owner SEE REMARK 1 f-prime capital partners healthcare fund v lp

2022-07-06 12:56:20 -0400 2022-07-01 S 38,775 $15.66 d 773,729 indirect 12.7914 43.0927 43.0927 6 0.0 1

FMR LLC - > 10% Owner SEE REMARK 1 f-prime capital partners healthcare fund v lp

2022-07-01 14:54:44 -0400 2022-06-30 S 18,810 $15.21 d 772,504 indirect 2.5592 31.0301 142.2265 142.2265 31 0.0 1

FMR LLC - > 10% Owner SEE REMARK 1 f-prime capital partners healthcare fund v lp

2022-07-01 14:54:44 -0400 2022-06-29 S 4,047 $15.50 d 821,676 indirect 2.5592 31.0301 142.2265 142.2265 31 0.0 1

FMR LLC - > 10% Owner SEE REMARK 1 f-prime capital partners healthcare fund v lp

2022-07-01 14:54:44 -0400 2022-06-29 S 30,362 $15.60 d 791,314 indirect 2.5592 31.0301 142.2265 142.2265 31 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VERVE THERAPEUTICS INC VERV 2022-08-16 22:15:05 UTC 1.2108 1.1092 1200000
VERVE THERAPEUTICS INC VERV 2022-08-16 21:45:03 UTC 1.2108 1.1092 1200000
VERVE THERAPEUTICS INC VERV 2022-08-16 21:15:03 UTC 1.2108 1.1092 1200000
VERVE THERAPEUTICS INC VERV 2022-08-16 20:45:05 UTC 1.2108 1.1092 1200000
VERVE THERAPEUTICS INC VERV 2022-08-16 20:15:04 UTC 1.2108 1.1092 1200000
VERVE THERAPEUTICS INC VERV 2022-08-16 19:45:04 UTC 1.2108 1.1092 1200000
VERVE THERAPEUTICS INC VERV 2022-08-16 19:15:05 UTC 1.2108 1.1092 1200000
VERVE THERAPEUTICS INC VERV 2022-08-16 18:45:04 UTC 1.2108 1.1092 1200000
VERVE THERAPEUTICS INC VERV 2022-08-16 18:15:05 UTC 1.2108 1.1092 1200000
VERVE THERAPEUTICS INC VERV 2022-08-16 17:45:04 UTC 1.2108 1.1092 1200000
VERVE THERAPEUTICS INC VERV 2022-08-16 17:15:04 UTC 1.2108 1.1092 1200000
VERVE THERAPEUTICS INC VERV 2022-08-16 16:45:04 UTC 1.2108 1.1092 1200000
VERVE THERAPEUTICS INC VERV 2022-08-16 16:15:04 UTC 1.2108 1.1092 1200000
VERVE THERAPEUTICS INC VERV 2022-08-16 15:45:04 UTC 1.2108 1.1092 1200000
VERVE THERAPEUTICS INC VERV 2022-08-16 15:15:03 UTC 1.2108 1.1092 1100000
VERVE THERAPEUTICS INC VERV 2022-08-16 14:45:03 UTC 1.2108 1.1092 1000000
VERVE THERAPEUTICS INC VERV 2022-08-16 14:15:04 UTC 1.2108 1.1092 1000000
VERVE THERAPEUTICS INC VERV 2022-08-16 13:45:05 UTC 1.2121 1.1079 1000000
VERVE THERAPEUTICS INC VERV 2022-08-16 13:15:04 UTC 1.2121 1.1079 1000000
VERVE THERAPEUTICS INC VERV 2022-08-16 12:45:03 UTC 1.2121 1.1079 1000000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund VERV -1800.0 shares, $-41076.0 2022-03-31 N-PORT
Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund VERV -3630.0 shares, $-54159.6 2022-04-30 N-PORT
Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund VERV -592.0 shares, $-8832.64 2022-04-30 N-PORT
RBB Fund, Inc.- Boston Partners Long/Short Research Fund VERV -25432.0 shares, $-385549.12 2022-05-31 N-PORT
Weiss Strategic Interval Fund- Weiss Strategic Interval Fund VERV -4948.0 shares, $-112913.36 2022-03-31 N-PORT

Elevate your investments